Vertex Pharmaceuticals, Inc. (VRTX)
$38.54
-0.38 (-0.98%)
| CAPS Rating |
|
|---|---|
| Open | $38.70 |
| Previous Close | $38.92 |
| Daily Range | $38.54 - $39.15 |
| 52-Week Range | $19.87 - $41.75 |
| Market Cap | $6.98B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,590,772 |
| Average Daily Volume | 2,829,000 |
VRTX
VS S&P 500 (SPY)
How do you think VRTX will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
VRTX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
VRTX News and Commentary
- Tech stocks off the beaten path – CNN Money
- Do You Have the Guts to Buy? – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Ockham Research on Vertex Pharmaceuticals, Inc. – Ockham-RazorWire
- CNBC on Vertex Pharmaceuticals, Inc. – Ockham-RazorWire
- Vertex hep C drug works well in twice daily dosing – Reuters
- Vertex hep C drug helps tough to treat patients – Reuters
- UPDATE 1-Vertex 3rd quarter net loss widens on costs – Reuters
- Texas gets 3 Billion for cancer research,this company has already Invested 2.8 Billion. – Blog at The Motley Fool
- A Plasma-tastic IPO – The Motley Fool
- UPDATE 1-Vertex sells future payments, sees wider '09 loss – Reuters
- I Can Bear to Look Again – Blog at The Motley Fool
- Don't Let Dummy Pills Make You a Dummy Investor – The Motley Fool
- Vertex Pulls a Wimpy – The Motley Fool
- Stocks Worth Waiting For – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- The Wrong Way to Invest in the Right Stocks – The Motley Fool
- Funding From an Unlikely Place – The Motley Fool
RSS Headlines
Fool UK
